POOLBEG PHARMA PLC ORD 0.02P(POLB)股吧_POOLBEG PHARMA PLC ORD 0.02P怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
20	0	Preclinical data posters presented at EHA Congress	POOLBEG PHARMA P资讯	06-11 02:55
15	0	Poolbeg Announces POLB 001 TOPICAL Site Activation	POOLBEG PHARMA P资讯	06-11 02:25
24	0	Results of AGM & Change of Registered Address	POOLBEG PHARMA P资讯	06-09 09:43
17	0	Pre-IND Meeting with the FDA for POLB 001	POOLBEG PHARMA P资讯	05-26 03:05
32	0	POLB 001 poster to be presented at EHA 2026	POOLBEG PHARMA P资讯	05-13 02:19
23	0	POLB 001 CRS patent granted in Canada	POOLBEG PHARMA P资讯	05-11 02:28
31	0	Annual Report & AGM Notice	POOLBEG PHARMA P资讯	05-07 02:34
27	0	Results for the year ended 31 December 2025	POOLBEG PHARMA P资讯	04-28 02:30
27	0	MHRA grants CTA for the POLB 001 TOPICAL trial	POOLBEG PHARMA P资讯	04-15 02:39
36	0	Significant milestone for Poolbeg's IP portfolio	POOLBEG PHARMA P资讯	03-31 02:25
42	0	Appointment of Dr Adrian Kilcoyne to SAB	POOLBEG PHARMA P资讯	03-12 03:31
42	0	Notification of Major Holdings	POOLBEG PHARMA P资讯	02-09 11:17
42	0	POLB 001 LPS Challenge Trial Paper Published	POOLBEG PHARMA P资讯	01-28 03:22
48	0	Exercise of Options & Total Voting Rights	POOLBEG PHARMA P资讯	01-27 10:33
36	0	Letter to Shareholders – 2025 a year of progress	POOLBEG PHARMA P资讯	12-18 03:26
54	0	POLB 001 to feature in CRS research programme	POOLBEG PHARMA P资讯	12-08 03:24
40	0	POLB 001 European Patent granted	POOLBEG PHARMA P资讯	11-20 03:23
46	0	Interim Results for the six months to 30 June 2025	POOLBEG PHARMA P资讯	09-29 02:26
44	0	POLB 001 Phase 2a Trial Update	POOLBEG PHARMA P资讯	09-25 02:21
46	0	Notification of Major Holdings	POOLBEG PHARMA P资讯	07-01 11:27
51	0	Notification of Major Holdings	POOLBEG PHARMA P资讯	06-26 03:34
49	0	Director/PDMR Shareholding	POOLBEG PHARMA P资讯	06-25 03:03
47	0	Results of GM and AGM Meetings	POOLBEG PHARMA P资讯	06-23 10:01
60	0	FDA Orphan Drug Designation granted for POLB 001	POOLBEG PHARMA P资讯	05-27 03:10
56	0	Annual Report, AGM Notice & Circular	POOLBEG PHARMA P资讯	05-27 02:31
52	0	Result of upsized oversubscribed BookBuild Offer	POOLBEG PHARMA P资讯	05-23 02:12
66	0	Increase of BookBuild Offer	POOLBEG PHARMA P资讯	05-22 08:46
48	0	Result of Placing and Notice of General Meeting	POOLBEG PHARMA P资讯	05-20 07:28
54	0	Proposed Retail Offer to raise up to ￡100,000	POOLBEG PHARMA P资讯	05-20 02:40
56	0	Results for the year ended 31 December 2024	POOLBEG PHARMA P资讯	05-20 02:19
52	0	Proposed Fundraising to raise approximately ￡4.1M	POOLBEG PHARMA P资讯	05-20 02:18
56	0	Conference Participation in March & April 2025	POOLBEG PHARMA P资讯	03-27 03:29
48	0	POLB 001 Patent Granted in Korea	POOLBEG PHARMA P资讯	03-20 03:23
61	0	Termination of proposed combination with HOOKIPA	POOLBEG PHARMA P资讯	02-21 03:14
68	0	Holding(s) in Company	POOLBEG PHARMA P资讯	02-19 01:37
67	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	02-19 01:06
77	0	Offer Update - Extension to PUSU Deadline	POOLBEG PHARMA P资讯	01-30 03:15
79	0	Replacement - Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-18 02:27
61	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-17 07:29
64	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-16 09:55
68	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-16 02:06
65	0	Form 8.3 - HOOKIPA Pharma Inc.	POOLBEG PHARMA P资讯	01-15 10:32
70	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-15 01:35
68	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-15 01:34
67	0	Form 8.3 - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-14 02:31
74	0	Update Potential Combination of Poolbeg & HOOKIPA	POOLBEG PHARMA P资讯	01-10 03:12
71	0	Holding(s) in Company	POOLBEG PHARMA P资讯	01-09 03:16
71	0	Form 8 (OPD) - Poolbeg Pharma plc	POOLBEG PHARMA P资讯	01-08 11:57
72	0	Update Potential Combination of Poolbeg & HOOKIPA	POOLBEG PHARMA P资讯	01-07 03:11
64	0	Combination of Poolbeg and HOOKIPA Pharma Inc.	POOLBEG PHARMA P资讯	01-02 03:18
83	0	Poolbeg presents POLB 001 data at 66th ASH Meeting	POOLBEG PHARMA P资讯	12-09 03:17
87	0	POLB 001 Patent Granted in United States	POOLBEG PHARMA P资讯	11-20 03:16
83	0	POLB 001 data to be presented at ASH	POOLBEG PHARMA P资讯	11-06 03:15
81	0	Interim results for the six months to 30 June 2024	POOLBEG PHARMA P资讯	09-18 02:18
76	0	H.C. Wainwright Global Investment Conference	POOLBEG PHARMA P资讯	08-27 03:17
73	0	Holding(s) in Company	POOLBEG PHARMA P资讯	08-12 09:44
76	0	Voluntary Delisting from OTCQB Market	POOLBEG PHARMA P资讯	07-26 03:08
100	0	Notification of Major Holdings	POOLBEG PHARMA P资讯	07-10 03:09
79	0	Change of Registered Address	POOLBEG PHARMA P资讯	07-02 03:20
82	0	Result of AGM	POOLBEG PHARMA P资讯	06-17 04:47
83	0	Annual Report & AGM Notice	POOLBEG PHARMA P资讯	05-09 03:08
74	0	Significant POLB 001 Patent Granted in USA	POOLBEG PHARMA P资讯	05-01 03:09
78	0	Option Agreement to Acquire Orphan Drug Candidate	POOLBEG PHARMA P资讯	04-30 03:12
77	0	Appointment of Joint Broker	POOLBEG PHARMA P资讯	04-30 03:07
77	0	Results for the year ended 31 December 2023	POOLBEG PHARMA P资讯	04-30 03:07
73	0	TR-1: Notification of major holdings	POOLBEG PHARMA P资讯	04-29 03:08
70	0	POLB 001 US Patent Update	POOLBEG PHARMA P资讯	03-20 04:05
78	0	Director/PDMR Shareholding	POOLBEG PHARMA P资讯	02-22 04:08
87	0	Director Share Purchase	POOLBEG PHARMA P资讯	02-19 10:46
85	0	Board Role Change and Launch of EIP	POOLBEG PHARMA P资讯	02-15 04:08
121	0	Market Opportunity for POLB 001 for CRS	POOLBEG PHARMA P资讯	02-12 04:08
85	0	Further data shows POLB001 potential in cancer CRS	POOLBEG PHARMA P资讯	01-17 04:09
110	0	RSV AI Drug Candidate Analysis Update	POOLBEG PHARMA P资讯	12-20 04:09
136	0	POLB 001 Data Presented at ASH	POOLBEG PHARMA P资讯	12-11 04:03
89	0	Directorate Change	POOLBEG PHARMA P资讯	11-30 04:10
96	0	Immunomodulator II patent granted in Japan	POOLBEG PHARMA P资讯	11-21 03:07
129	0	POLB 001 LPS Trial Data to be Presented at IUIS	POOLBEG PHARMA P资讯	11-16 03:07
121	0	Former Amryt Pharma Leadership Team join Poolbeg	POOLBEG PHARMA P资讯	11-09 04:13
129	0	POLB001 Data to be Presented at ASH Annual Meeting	POOLBEG PHARMA P资讯	11-03 04:22
107	0	POLB 001 Oncology Programme Update Meeting	POOLBEG PHARMA P资讯	11-01 04:10

emytylist